PLSE
Pulse Biosciences Inc
$19.25
$0.00(0.00%)
42
Overall
40
Value
63
Tech
23
Quality
Market Cap
$1.18B
Volume
169.49K
52W Range
$12.56 - $26.30
Target Price
$30.00
Company Overview
| Mkt Cap | $1.18B | Price | $19.25 |
| Volume | 169.49K | Change | +0.00% |
| P/E Ratio | -22.1 | Open | $18.72 |
| Revenue | -- | Prev Close | $19.25 |
| Net Income | $-53.6M | 52W Range | $12.56 - $26.30 |
| Div Yield | N/A | Target | $30.00 |
| Overall | 42 | Value | 40 |
| Quality | 23 | Technical | 63 |
No chart data available
About Pulse Biosciences Inc
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Latest News
Pulse Biosciences appoints new COO to advance commercialization
TipRanks Auto-Generated Newsdesk•19 hours ago
Pulse Biosciences Launches Pivotal NANOPULSE-AF Clinical Study
TipRanks Auto-Generated Newsdesk•3 days ago
Pulse Biosciences Grants RSUs to Chief Technology Officer
TipRanks Auto-Generated Newsdesk•14 days ago
Pulse Biosciences Launches Thyroid Cancer Feasibility Study
TipRanks Auto-Generated Newsdesk•a month ago
Pulse Biosciences Launches Thyroid Cancer Feasibility Study
TipRanks Auto-Generated Newsdesk•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PLSE | $19.25 | 0% | 169.49K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |